What is the recommended management for a child with severe croup (laryngotracheobronchitis)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Severe Croup Management

For severe croup (laryngotracheobronchitis), immediately administer nebulized epinephrine (0.5 mL/kg of 1:1000 solution, maximum 5 mL) combined with a single dose of dexamethasone (0.6 mg/kg, maximum 12 mg) orally, intramuscularly, or intravenously.

Immediate Treatment Algorithm

First-Line Therapy (Administer Simultaneously)

Nebulized Epinephrine:

  • Dose: 0.5 mL/kg of 1:1000 L-epinephrine solution (maximum 5 mL) via nebulizer 1, 2
  • Alternative: Racemic epinephrine 2.25% solution at 0.5 mL (standard dose for all patients) in 2 mL normal saline 1
  • Critical caveat: Effect is short-lived (1-2 hours), so prepare for potential repeat dosing 2

Corticosteroids:

  • Dexamethasone 0.6 mg/kg (maximum 12 mg) as single dose 3, 4, 5
  • Routes in order of preference: oral > intramuscular > intravenous 6
  • If oral route not tolerated: give IM or IV dexamethasone 6

Supportive Care

  • Humidified oxygen if SpO2 persistently <90% 7
  • Keep child calm (agitation worsens obstruction)
  • Position of comfort (typically upright in caregiver's arms)

Monitoring and Repeat Dosing

Observe for 2-4 hours after initial epinephrine dose 2:

  • Epinephrine can be repeated every 20 minutes if needed (up to 3 doses) 1
  • Most children respond within first 1-2 hours
  • If requiring ≥3 doses of epinephrine or persistent severe distress, prepare for possible intubation

Admission Criteria

Admit to hospital if:

  • Requiring more than 2 doses of nebulized epinephrine 8
  • Persistent stridor at rest after treatment
  • Significant respiratory distress (retractions, nasal flaring, hypoxia)
  • Inability to maintain oral hydration
  • Concerns about caregiver ability to monitor at home

Transfer to ICU if:

  • Impending respiratory failure (decreased level of consciousness, severe retractions, cyanosis)
  • Requiring continuous nebulized epinephrine
  • Need for intubation 2

Critical Pitfalls to Avoid

  1. Do NOT discharge patients shortly after epinephrine administration - the effect wears off in 1-2 hours and symptoms may rebound 2

  2. Do NOT use nebulized steroids (budesonide) as first-line - while they may reduce symptoms in first 2 hours, systemic dexamethasone is superior and standard of care 2

  3. Do NOT perform chest physiotherapy - it provides no benefit 9

  4. Do NOT routinely order radiographs or laboratory studies - croup is a clinical diagnosis 3, 4

  5. Ensure correct epinephrine concentration - use 1:1000 (1 mg/mL) for nebulization, NOT 1:10,000 1

What NOT to Use

  • Antibiotics (unless bacterial superinfection suspected) 9
  • Ribavirin (not indicated for croup) 9
  • Routine bronchodilators like albuterol (ineffective for croup) 9

Evidence Strength

The recommendation for combined corticosteroids and nebulized epinephrine in severe croup is supported by high-quality evidence from multiple guidelines 1, 2 and research studies 3, 4, 6, 5. The American Academy of Pediatrics 1 and British Thoracic Society 2 guidelines provide consistent dosing recommendations. Simultaneous administration of corticosteroids and epinephrine reduces intubation rates in severe croup 6.

The key distinction from mild-moderate croup is that severe cases require both epinephrine and steroids immediately, whereas mild cases may only need dexamethasone alone 4, 5.

References

Research

Croup: Diagnosis and Management.

American family physician, 2018

Research

Acute management of croup in the emergency department.

Paediatrics & child health, 2017

Research

Croup: Rapid Evidence Review.

American family physician, 2026

Research

Viral croup: a current perspective.

Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners, 2004

Research

The management of croup.

British medical bulletin, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.